Chordia Therapeutics,IncJP:190A
| Aug 31, 2021 | Aug 31, 2022 | Aug 31, 2023 |
---|
Cash and deposits | - | 4,255 | 4,799 |
---|
Advance payments to suppliers | - | 19 | 41 |
---|
Prepaid expenses | - | 65 | 52 |
---|
Other | - | 143 | - |
---|
Current assets | - | 4,482 | 4,892 |
---|
Tools, furniture and fixtures | - | 10 | 11 |
---|
Accumulated depreciation | - | -2 | -6 |
---|
Tools, furniture and fixtures, net | - | 8 | 4 |
---|
Property, plant and equipment | - | 8 | 4 |
---|
Software | - | 4 | 2 |
---|
Intangible assets | - | 4 | 2 |
---|
Long-term prepaid expenses | - | 2 | 9 |
---|
Other | - | 3 | 2 |
---|
Investments and other assets | - | 5 | 11 |
---|
Non-current assets | - | 17 | 18 |
---|
Assets | - | 4,499 | 4,909 |
---|
Accounts payable - other | - | 140 | 248 |
---|
Accrued expenses | - | 14 | 10 |
---|
Provision for bonuses | - | 23 | 16 |
---|
Income taxes payable | - | 2 | 2 |
---|
Provision for bonuses for directors (and other officers) | - | 4 | - |
---|
Other | - | 38 | 132 |
---|
Income taxes payable | - | 2 | 2 |
---|
Current liabilities | - | 221 | 408 |
---|
Other | - | 38 | 132 |
---|
Current liabilities | - | 221 | 408 |
---|
Liabilities | - | 221 | 408 |
---|
Share capital | - | 90 | 90 |
---|
Legal capital surplus | - | 5,407 | 5,407 |
---|
Other capital surplus | - | 2,873 | 2,873 |
---|
Capital surplus | - | 8,280 | 8,280 |
---|
Capital surplus | - | 8,280 | 8,280 |
---|
Retained earnings brought forward | - | -4,118 | -3,895 |
---|
Retained earnings | - | -4,118 | -3,895 |
---|
Retained earnings | - | -4,118 | -3,895 |
---|
Shareholders' equity | - | 4,252 | 4,475 |
---|
Share acquisition rights | - | 26 | 26 |
---|
Net assets | 2,056 | 4,278 | 4,501 |
---|
Liabilities and net assets | - | 4,499 | 4,909 |
---|